91 related articles for article (PubMed ID: 17426052)
21. MicroRNA expression profiling in prostate cancer.
Porkka KP; Pfeiffer MJ; Waltering KK; Vessella RL; Tammela TL; Visakorpi T
Cancer Res; 2007 Jul; 67(13):6130-5. PubMed ID: 17616669
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549.
Fang L; Min L; Lin Y; Ping G; Rui W; Ying Z; Xi W; Ting H; Li L; Ke D; Jihong R; Huizhong Z
Cell Signal; 2010 Jan; 22(1):166-73. PubMed ID: 19786090
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
24. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
25. TfR2 expression in human colon carcinomas.
Calzolari A; Deaglio S; Maldi E; Cassoni P; Malavasi F; Testa U
Blood Cells Mol Dis; 2009; 43(3):243-9. PubMed ID: 19729324
[TBL] [Abstract][Full Text] [Related]
26. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
[TBL] [Abstract][Full Text] [Related]
27. Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription.
Lössner D; Abou-Ajram C; Benge A; Aumercier M; Schmitt M; Reuning U
J Cell Physiol; 2009 Aug; 220(2):367-75. PubMed ID: 19334037
[TBL] [Abstract][Full Text] [Related]
28. Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility.
Solé X; Hernández P; de Heredia ML; Armengol L; Rodríguez-Santiago B; Gómez L; Maxwell CA; Aguiló F; Condom E; Abril J; Pérez-Jurado L; Estivill X; Nunes V; Capellá G; Gruber SB; Moreno V; Pujana MA
BMC Genomics; 2008 Jan; 9():12. PubMed ID: 18190704
[TBL] [Abstract][Full Text] [Related]
29. Cell growth stimulation by CRASH, an asparaginase-like protein overexpressed in human tumors and metastatic breast cancers.
Weidle UH; Evtimova V; Alberti S; Guerra E; Fersis N; Kaul S
Anticancer Res; 2009 Apr; 29(4):951-63. PubMed ID: 19414332
[TBL] [Abstract][Full Text] [Related]
30. Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression.
He Y; Franco OE; Jiang M; Williams K; Love HD; Coleman IM; Nelson PS; Hayward SW
Cancer Res; 2007 Sep; 67(17):8188-97. PubMed ID: 17804732
[TBL] [Abstract][Full Text] [Related]
31. Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.
McCarthy HO; Coulter JA; Worthington J; Robson T; Hirst DG
J Gene Med; 2007 Jun; 9(6):511-20. PubMed ID: 17471586
[TBL] [Abstract][Full Text] [Related]
32. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
[TBL] [Abstract][Full Text] [Related]
33. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.
Fernández-Martínez AB; Collado B; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
Mol Cell Endocrinol; 2007 May; 270(1-2):8-16. PubMed ID: 17434257
[TBL] [Abstract][Full Text] [Related]
34. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.
Zhang H; Zhao Q; Chen Y; Wang Y; Gao S; Mao Y; Li M; Peng A; He D; Xiao X
Thorax; 2008 Apr; 63(4):352-9. PubMed ID: 18364444
[TBL] [Abstract][Full Text] [Related]
35. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
36. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
Cafferata EG; Macció DR; Lopez MV; Viale DL; Carbone C; Mazzolini G; Podhajcer OL
Clin Cancer Res; 2009 May; 15(9):3037-49. PubMed ID: 19336523
[TBL] [Abstract][Full Text] [Related]
37. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
38. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1).
Perez M; Peinado-Serrano J; Garcia-Heredia JM; Felipe-Abrio I; Tous C; Ferrer I; Martin-Broto J; Saez C; Carnero A
Oncotarget; 2016 Oct; 7(41):67033-67046. PubMed ID: 27563810
[TBL] [Abstract][Full Text] [Related]
40. MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy.
Rivero M; Peinado-Serrano J; Muñoz-Galvan S; Espinosa-Sánchez A; Suarez-Martinez E; Felipe-Abrio B; Fernández-Fernández MC; Ortiz MJ; Carnero A
Oncotarget; 2018 Aug; 9(68):32958-32971. PubMed ID: 30250642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
